Trial intelligence / Profile preview

HepB-BirD: Hepatitis B Birth Dose in Neonates

NCT04870021Phase 4Completed

Sponsor
Quaid-i-Azam University
Start
Mar 2015
Primary completion
Nov 2015
Modality
Split/Subunit Vaccines, Recombinant Protein Vaccines
Countries
1
01

Overview

A Phase 4 trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by Quaid-i-Azam University. Started Mar 2015; status: completed.

02

Drugs

Hepatitis B vaccine
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on NCT04870021.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04870021.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call